Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
Striatal dopamine mediates hallucination-like perception in mice
Alpha Lipoic Acid (700mg): ALA is called a "universal antioxidant." It works with glutathione to recycle it and enhance its benefits
Boosts Energy & Mental Clarity : By supporting mitochondrial health, glutathione increases energy production, enhances focus, and combats brain fog
Conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and Hashimoto's thyroiditis are linked to oxidative stress and immune system imbalances[4]